Podcasts about keck school

Tired of ADHD strategies that don't work? Here's what actually does. FREE training here: https://programs.tracyotsuka.com/signup_____A 10-year-old boy sat across from Dr. Kalaki Clarke, MD during her psychiatry rotation, and she saw herself. Smart, charming, good grades but couldn't get it together. That's when she knew she had ADHD too.Dr. Clarke was in her first year of residency at UC Irvine, working 80-hour weeks in a system designed to test you constantly. She'd been the good kid, the high achiever, the one who always kept it together. But in residency, surrounded by neurotypical colleagues, sleep-deprived, and constantly performing, the mask finally came off. Her 2015 diagnosis became a turning point, launching her into advocacy for physicians with ADHD. She helped craft equity guidelines for neurodivergent resident physicians, spoke at the International Conference on ADHD, and delivered a TEDx talk called "Seeing is Freeing: How Observation Releases ADHD Potential."Now, as a board-certified family physician and Associate Professor of Medical Education at USC's Keck School of Medicine, Dr. Clarke spends her time providing care for underserved communities in Los Angeles while shaping the next generation of doctors.In this conversation, Dr. Clarke and Tracy talk about what it's like to have ADHD in a profession that demands perfection and how "seeing is freeing" applies to both patients and physicians. Dr. Clarke introduces her CAT method (Capture, Analyze, Transform), a framework for turning struggles into strategies. She also talks about leading by example, why she came out publicly about her ADHD at work, and what it means to create space for others to be seen when you've spent so long feeling invisible yourself.Resources: Linkedin: https://www.linkedin.com/in/kmclarkemd Instagram: https://www.instagram.com/this_md_kalaki/ TEDx Talk: https://www.youtube.com/watch?v=CKmRyxlas3ISend a Message: Your Name | Email | Message If this podcast helps you understand your ADHD brain, Shift helps you train it. Practice mindset work in just 10 minutes a day. Learn more at tracyotsuka.com/shift Instead of Struggling to figure out what to do next? ADHD isn't a productivity problem. It's an identity problem. That's why most strategies don't stick—they weren't designed for how your brain actually works. Your ADHD Brain is A-OK Academy is different. It's a patented, science-backed coaching program that helps you stop fighting your brain and start building a life that fits.

We discuss early results from the study of photobiomodulation for the treatment of dry AMD with Dr. David Boyer, Adjunct Professor of Clinical Ophthalmology,  Keck School of Medicine of USC, Roski Eye Institute.

Send us a textEdward You is recently coming off an amazing career at the U.S. Federal Bureau of Investigation (FBI) where most recently he served in roles as Supervisory Special Agent, National Counterintelligence Task Force, Counterintelligence Division, as well as a Supervisory Special Agent in the FBI's Weapons of Mass Destruction Directorate.  He was also previously simultaneously detailed as a Liaison Officer at the Department of Health and Human Services, Office of National Security, and as a National Counterintelligence Officer for Emerging and Disruptive Technologies, in the Office of the Director of National Intelligence (ODNI).Mr. You was responsible for creating programs and activities to coordinate and improve FBI and interagency activities to identify, assess, and respond to biological threats or incidents.  He supported FBI initiatives to build partnerships with the life sciences community, domestically and internationally, and lead efforts to identify and address potential security challenges in advanced biotechnology. His overall goal was to safeguard the scientific community, the life science research enterprise, and the U.S. bioeconomy.  Before being promoted to the Weapons of Mass Destruction Directorate, Mr. You served as a member of the FBI Los Angeles Field Office Joint Terrorism Task Force and the FBI Hazardous Evidence Response Team. Mr. You has also been directly involved in policy-making efforts with a focus on biosecurity.  He served as an active Working Group member of the White House National Security Council Policy Coordinating Committee on Countering Biological Threats and represented the FBI as an Ex Officio member of the National Institutes of Health National Science Advisory Board for Biosecurity.  He also served on two National Academies of Sciences, Engineering, and Medicine Committees, the Institute of Medicine's Forum on Microbial Threats and the Committee on Science, Technology, and Law's Forum on Synthetic Biology.  He is currently a Senior Fellow for the Scowcroft Institute of International Affairs at the Bush School of Government and Public Service at Texas A&M University.Prior to joining the FBI, Mr. You had extensive experience in academic research having worked for three years in autoimmune disease research at the Cedars-Sinai Medical Center and six years in human gene therapy and retrovirology at the University of Southern California, Keck School of Medicine, where he received his Master of Science (M.S.), Biochemistry and Molecular Biology.  Just prior to joining the FBI, Mr. You worked for three years in the commercial biotechnology sector conducting cancer research and assay development at AMGEN, Inc.Mr. You recently set up EHY Consulting LLC, dedicated to consulting activities focused on safeguarding science and innovation at the intersection of biotechnology, artificial intelligence, and national security.#EdwardYou #FederalBureauOfInvestigation #WeaponsOfMassDestructionDirectorate #FBI #SupervisorySpecialAgent #Biosecurity #Bioeconomy #Biohackers #DualUse #Anthrax #Ricin #FBIHazardousEvidenceResponseTeam #JointTerrorismTaskForce #AutoimmuneDisease #MolecularBiology #GeneTherapy #Angiogenesis #WMDCoordinator #Chemical #Biological #CBRN #UnitedNationsInterregionalCrimeAndJusticeResearchInstitute #UNICRI #NationalAcademies #NationalCounterintelligenceAndSecurityCenter #OfficeOfTheDirectorOfNationalIntelligence #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #ResearchSupport the show

This content was funded by Boehringer Ingelheim, who had no influence or involvement in the development of the content. This material is intended for U.S. healthcare professionals. Pulmonary fibrosis remains one of the most challenging respiratory diseases – often underdiagnosed, undertreated, and misunderstood. In this AMJ podcast, Ayodeji Adegunsoye and Toby Maher share their expert perspectives on how the field is changing, how recent data are shaping clinical decision-making, and why holistic, patient-centered care is critical. Chapters:  03:02 – 15:34 – A Decade Without New Options 15:34 – 27:47 – Understanding the Latest Clinical Trial Data 27:47 – 39:28 – From Hesitancy to Action: Reaching the Community Clinician 39:28 – 54:10 – Psychosocial Support and Patient-Centered Care 54:10 – 01:02:07 – The Role of Primary Care in ILD Diagnosis 01:02:07 – 1:07:48 – Call to Action  Speakers: Ayodeji Adegunsoye, MD, PhD – Assistant Professor of Medicine, Biological Sciences Division, University of Chicago, Illinois, USA Toby Maher, MD, PhD – Professor of Clinical Medicine, Keck School of Medicine, University of Southern California, USA

Dean's Chat hosts, Drs. Jensen and Richey, welcome Dr. JD Shih to the podcast! Dr. JD Shih, DPM, MPH Assistant Professor, Clinical Surgery — Keck Medicine of USC Podiatric Surgeon • Limb Salvage Specialist • Public Health Advocate This episode is sponsored by Bako Diagnostics! Dr. JD Shih is a board-certified podiatric surgeon specializing in chronic foot and ankle wounds, reconstructive surgery, limb preservation, and biomechanics.  He holds dual board certification from the American Board of Podiatric Medicine and the American Board of Foot and Ankle Surgery.  He earned his Doctorate of Podiatric Medicine (with honors) from the California School of Podiatric Medicine at Samuel Merritt University, followed by a residency in podiatric medicine and surgery (PMSR/RRA) through the VA and affiliated hospitals in Los Angeles.  In 2019, he completed a fellowship in limb preservation (Lawrence B. Harkless Fellowship) at Keck Medicine of USC.  Fueled by a passion to reduce preventable amputations, Dr. Shih also obtained a Master's in Public Health from Dartmouth's Geisel School of Medicine.  His research spans diabetic foot epidemiology, prevention strategies, imaging diagnostics in foot and ankle disease, disparities in care, and wound management biomechanics.  He has been honored with the Arthur E. Helfand Award for research excellence and the John & Janet Carson Public Health Advocacy Award.  He is active in the American Podiatric Medical Association, California Podiatric Medical Association, and the American Association of Colleges of Podiatric Medicine (where he serves as mentor).  Originally from Taipei, Taiwan, Dr. Shih has lived in the U.S. for much of his life, training and practicing on both coasts.  His care philosophy centers on partnership: he seeks to work closely with patients and families, combining evidence-based medicine, interdisciplinary care, and personalized planning to optimize outcomes.

Season FIVE Episode THREE of the Your Story Our Fight® podcast welcomes Rachel Carmen Ceasar. Rachel Carmen Ceasar is a medical anthropologist and public health researcher committed to helping people make informed health decisions rooted in science and evidence. She holds a PhD in Medical Anthropology from the University of California, Berkeley, and currently serves as an Assistant Professor at the Keck School of Medicine at the University of Southern California, in the Department of Population and Public Health Sciences.Her research focuses on the use of cannabis across women's lifespans, including during pregnancy and postpartum (at the Maternal Cannabis Lab). In addition to her academic work, Rachel is the founder of Culture of Health & Tech, a user experience research consultancy through which she advises health and technology organizations such as Centene, Kaiser Permanente, and Baxter. Rachel is also a lupus warrior and passionate advocate for reproductive health. She is the mother of a 7-year-old and, after experiencing four miscarriages, she turned to extensive research on the intersection of lupus and fertility. With the guidance of her rheumatologist, Dr. Leanna Wise, and the support of evidence-based care, Rachel welcomed a baby boy in 2024 — a journey that continues to inform her advocacy for reproductive health in the lupus community.

In this episode, Lillian Erdahl, MD, FACS, is joined by Jordan Rook, MD, from UCLA, and Lorraine Kelley-Quon, MD, FACS, from Children's Hospital Los Angeles and Keck School of Medicine of USC. They discuss Drs Rook and Kelley-Quon's recent article, “Expanding the Public Health Role of Pediatric Trauma Centers: Drug Screening for Adolescent Trauma Patients,” in which the authors found that biochemical drug screening for injured adolescents is decreasing at pediatric trauma centers, despite increasing national adolescent overdose deaths. Given high rates of substance use among injured adolescents, this is a missed opportunity to intervene on problematic substance use and prevent future adolescent overdose deaths.   Disclosure Information: Drs Rook, Kelley-Quon, and Erdahl have nothing to disclose. To earn 0.25 AMA PRA Category 1 Credits™ for this episode of the JACS Operative Word Podcast, click here to register for the course and complete the evaluation. Listeners can earn CME credit for this podcast for up to 2 years after the original air date.   Learn more about the Journal of the American College of Surgeons, a monthly peer-reviewed journal publishing original contributions on all aspects of surgery, including scientific articles, collective reviews, experimental investigations, and more.   #JACSOperativeWord

Send us a textDr. Neal Baer, MD ( https://en.wikipedia.org/wiki/Neal_Baer ) is an award-winning showrunner, television writer/producer, physician, author, and a public health advocate and expert.Dr. Baer lectures on Global Health and Social Medicine and is the Co-Director of the master's degree program in Media, Medicine, and Health at Harvard Medical School ( https://ghsm.hms.harvard.edu/faculty-staff/neal-baer ). Previously, Dr. Baer was Clinical Professor of Preventive Medicine at the Keck School of Medicine at the University of Southern California and an Adjunct Professor in the Department of Community Health at the Fielding School of Public Health at UCLA where he established the Global Media Center for Social Impact using new media to promote global health.Dr. Baer  was an Executive Producer and showrunner for Designated Survivor, Under the Dome, Law & Order: Special Victims Unit, and a writer and producer on ER ( https://www.imdb.com/name/nm0046371/ ). Dr. Baer is an accomplished author with both fictional novels, including Kill Switch and Kill Again, and non-fiction titles, including The Promise and Peril of CRISPR ( https://www.amazon.com/Promise-Peril-CRISPR-Neal-Baer/dp/1421449307 ), a timely collection of essays on the pressing possibilities and risks of gene-editing technology, available at major booksellers.Dr. Baer graduated from Harvard Medical School and completed his internship in Pediatrics at Children's Hospital, Los Angeles. He received the Jerry L. Pettis Memorial Scholarship from the American Medical Association as the most outstanding medical student who has contributed to promoting a better understanding of medicine in the media.  The American Association for the Advancement of Science selected him as a Mass Media Fellow.#NealBaer #HarvardMedicalSchool #CRISPR #GeneEditing #Pediatrics #DesignatedSurvivor #UnderTheDome #LawAndOrderSpecialVictimsUnit #ER #SocialImpact #PublicHealth #GlobalHealth #JenniferDoudna #EmmanuelleCharpentier #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #Podcasting #ViralPodcast #STEM #Innovation #Science #Technology #ResearchSupport the show

Send us a textIn this episode, we welcome Dr. Bianca Edison, a pediatric sports medicine and orthopedic physician, to discuss the critical issues surrounding youth sports. Dr. Edison shares her journey into sports medicine and emphasizes the importance of balancing athletic activities for young athletes. The discussion covers overtraining, the significance of rest and recovery, the impact of burnout, and practical advice for preventing common sports injuries in children. We also dive into the importance of sleep, quality nutrition, and healthy exercise habits. This episode offers valuable insights for parents, coaches, and young athletes aiming for long-term health and enjoyment in sports. Dr. Bianca Edison is a pediatric sports medicine and orthopedic physician at Children's Hospital Los Angeles and Clinical Associate Professor of Orthopedic Surgery at USC's Keck School of Medicine. She received her MD from Baylor College of Medicine, completed pediatrics internship and residency at UCLA (where she served as Chief Resident), and pursued a sports medicine fellowship at CHLA. Bianca's clinical work focuses on overuse injuries, injury prevention, dance medicine, and concussion—helping young athletes stay healthy and love movement for life.Your Child is Normal is the trusted podcast for parents, pediatricians, and child health experts who want smart, nuanced conversations about raising healthy, resilient kids. Hosted by Dr. Jessica Hochman — a board-certified practicing pediatrician — the show combines evidence-based medicine, expert interviews, and real-world parenting advice to help listeners navigate everything from sleep struggles to mental health, nutrition, screen time, and more. Follow Dr Jessica Hochman:Instagram: @AskDrJessica and Tiktok @askdrjessicaYouTube channel: Ask Dr Jessica If you are interested in placing an ad on Your Child Is Normal click here or fill out our interest form.-For a plant-based, USDA Organic certified vitamin supplement, check out : Llama Naturals Vitamin and use discount code: DRJESSICA20-To test your child's microbiome and get recommendations, check out: Tiny Health using code: DRJESSICA The information presented in Ask Dr Jessica is for general educational purposes only. She does not diagno...

On this episode of the Family Docs Podcast, Dr. Cynthia Chen-Joea discusses physician wellness and the pursuit to recapture the joy in medicine with Drs. Lauren Brown-Berchtold and Kim Yu.  Guests: Cynthia Chen-Joea, DO, MPH, CPH, FAAFP - Dr. Cynthia Chen-Joea is a physician career and life coach, double board-certified in Family Medicine and Obesity Medicine, and the founder of Thrivation, dedicated to coaching early-career physicians break free from burnout and build sustainable, fulfilling careers. She is also the co-founder of Physician Contract Negotiation, empowering physicians to advocate for their worth and navigate their careers with confidence. She serves as the Director of Inpatient Medicine at Charles Drew Family Medicine Residency Program and Medical Director of Copa de Oro Medical Group.  Her previous leadership positions include, Physician Advisor, Secretary-Treasurer of the Medical Staff and Department Chair of Family Medicine at Emanate Health.   A passionate advocate for physician well-being and healthcare transformation, Dr. Chen-Joea has held multiple leadership roles at the local, state, and national levels working in advocacy within her specialty organization. She currently serves as the New Physician member on the AAFP Board of Directors, working to create a more sustainable future in medicine.   Kim Yu, MD, FAAFP, DABFM - Dr. Kim Yu is a national and international speaker, executive family physician leader, past president of the Michigan Academy of Family Physicians, and current Speaker of the California Academy of Family Physicians. Based out of California, Dr. Yu lives to #inspirecreatelead and currently works at the American Board of Family Medicine as the PRIME National Strategy Consultant and as Director of Health Care Strategy at KCS Inc., a multisite FQHC in Orange County, CA, serving the Asian community and the underserved in Southern California. Dr. Yu has served as the chair for the AAFP's Global Health Member Interest Group and as convener for WONCA's Special Interest Group in Health Equity. She currently serves on the AAFP delegation to the AMA, Wonca Working Party of Women in Family Medicine - USA country lead,  and has interests in physician wellbeing, population health, practice management, health IT, value based care, global health, health equity, advocacy, disaster relief, and a wide range of primary care topics.  Lauren Brown-Berchtold, MD, FAAFP -  Dr. Lauren Brown-Berchtold is the program director for the Valley Consortium for Medical Education (VCME) Family Medicine Residency program in Modesto, California. She previously was a core faculty member and later program director of San Joaquin General Hospital for 8 years in total. She graduated from Keck School of Medicine of USC in Los Angeles, then joined John Peter Smith Hospital in Fort Worth, Texas, to complete her family medicine residency and Maternal-Child Health fellowship equivalent training. Dr. Brown-Berchtold is a fervent advocate for physician mental health protections and burnout prevention, and spends a lot of extracurricular time working on this topic nationally. When away from the hospital, she loves to read as well as explore life with her husband and very active daughter! Resources: https://www.aafp.org/pubs/fpm/issues/2018/0700/p38.html Dr. Kim Yu Finds ‘Reason for Being' in Family Medicine Advocacy - https://www.theabfm.org/dr-kim-yu-finds-reason-for-being-in-family-medicine-advocacy/ Ikigai - https://en.wikipedia.org/wiki/Ikigai / https://positivepsychology.com/ikigai/  26 hours of work per day: https://link.springer.com/article/10.1007/s11606-022-07707-x Weidner AKH, Phillips RL Jr, Fang B, Peterson LE. Burnout and Scope of Practice in New Family Physicians [published correction appears in Ann Fam Med. 2018 Jul;16(4):289. doi: 10.1370/afm.2281]. Ann Fam Med. 2018;16(3):200-205. doi:10.1370/afm.2221 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951247/ Pixar Films mentioned - Inside Out and Inside Out 2 Learned helplessness - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920136/  Job crafting - Amy Wrzesniewski - https://hbr.org/2010/06/managing-yourself-turn-the-job-you-have-into-the-job-you-want  Baader-Meinhof phenomenon / frequency illusion - https://www.psychologytoday.com/us/basics/frequency-illusion  Nine recs for physician wellbeing for c-suite article: Shanafelt TD, Noseworthy JH. Executive Leadership and Physician Well-being: Nine Organizational Strategies to Promote Engagement and Reduce Burnout. Mayo Clin Proc. 2017;92(1):129-146. doi:10.1016/j.mayocp.2016.10.004.  https://www.mayoclinicproceedings.org/article/S0025-6196(16)30625-5/pdf  AMA Cost Of Burnout:  https://edhub.ama-assn.org/steps-forward/interactive/16830405  Physician coaching: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2740206  Family Medicine POP: Prism of Practice conference, September 5-7, 2025 (San Diego) - www.familydocs.org/pop CAFP's All Member Advocacy Meeting (AMAM), March 14-16, 2026 (Sacramento) - www.familydocs.org/amam  Information: The Family Docs Podcast is hosted by Rob Assibey, MD, FAAFP and Cynthia Chen-Joea, DO, FAAFP.  The Family Docs podcast is developed, produced, and recorded by the California Academy of Family Physicians. The views and opinions expressed in this program are those of the speakers and do not necessarily reflect the views or positions of any entities they represent or the California Academy of Family Physicians. More information at www.familydocs.org/podcast. Visit the California Academy of Family Physicians online at www.familydocs.org. Follow us on social media: Twitter - https://twitter.com/cafp_familydocs  Instagram - https://www.instagram.com/cafp_familydocs  Facebook - https://www.facebook.com/familydocs  LinkedIn - https://www.linkedin.com/company/california-academy-of-family-physicians 

E-cigarette use is declining, but nicotine pouch usage is on the rise. Dae Hee Han, researcher associate in the department of population and public health sciences at the Keck School of Medicine at the University of Southern California, delves into why. As a behavioral scientist, Dr. Dae-Hee Han specializes in investigating the behavioral and health-related […]

As part of the 2025 Developmental Disabilities Conference, Yao Du from the Keck School of Medicine at USC, talk about the risks and benefits of technology and generative AI. Series: "Developmental Disabilities Update" [Health and Medicine] [Show ID: 40624]

As part of the 2025 Developmental Disabilities Conference, Yao Du from the Keck School of Medicine at USC, talk about the risks and benefits of technology and generative AI. Series: "Developmental Disabilities Update" [Health and Medicine] [Show ID: 40624]

As part of the 2025 Developmental Disabilities Conference, Yao Du from the Keck School of Medicine at USC, talk about the risks and benefits of technology and generative AI. Series: "Developmental Disabilities Update" [Health and Medicine] [Show ID: 40624]

Following the FDA approval of taletrectinib (Ibtrozi) for patients with locally advanced or metastatic ROS1-positive non–small cell lung cancer (NSCLC), CancerNetwork® spoke with Jorge Nieva, MD, about how this regulatory decision may impact the treatment paradigm for this disease. The approval was supported by findings from the phase 2 TRUST-I trial (NCT04395677) and the phase 2 TRUST-II trial (NCT04919811). The total efficacy population included 157 patients who had no prior treatment with a ROS1 tyrosine kinase inhibitor (TKI) and 113 who were previously treated with a ROS1 TKI. Topline results showed an objective response rate (ORR) of 90% (95% CI, 83%-95%) in TRUST-I and 85% (95% CI, 73%-93%) in TRUST-II among patients who had no prior treatment. Of those with pretreated disease, the respective ORRs were 52% (95% CI, 39%-64%) and 62% (95% CI, 46%-75%) in each study population. According to Nieva, an associate professor of clinical medicine at the Keck School of Medicine of the University of Southern California, taletrectinib may offer advantages over other therapies in the ROS1-positive metastatic NSCLC space based on its improved central nervous system (CNS) toxicity profile and “excellent” response and progression-free survival data. He stated that taletrectinib would become the go-to first-line agent in his practice. Additionally, he discussed strategies for mitigating toxicities related to taletrectinib such as nausea and diarrhea, and highlighted the need for additional research to improve immunotherapy options in NSCLC.  “I'm very happy that we have choices for patients, and I'm very happy that we have such a wide variety of drugs, but we still need to do better, and we need to find better ways of using these agents because they're still not cures for the majority of patients,” Nieva stated. “While these drugs can be helpful at debulking tumors, we still need to do a lot more work [to do] on making this a disease of the past for those patients who have it.” Reference FDA approves taletrectinib for ROS1-positive non-small cell lung cancer. News release. FDA. June 11, 2025. Accessed July 8, 2025. https://tinyurl.com/yc4f379m

This episode recorded live at the Becker's 22nd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference features Michael Bottros, Clinical Operations Chief and Medical Director for Pain Services, Department of Anesthesiology, Keck School of Medicine of USC. He shares key trends in non-opioid pain management, the shift toward curative procedures, and how innovation, workforce investment, and care path efficiency are shaping the future of outpatient spine and orthopedic care.

This episode recorded live at the Becker's 22nd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference features Michael Bottros, Clinical Operations Chief and Medical Director for Pain Services, Department of Anesthesiology, Keck School of Medicine of USC. He shares key trends in non-opioid pain management, the shift toward curative procedures, and how innovation, workforce investment, and care path efficiency are shaping the future of outpatient spine and orthopedic care.

This episode recorded live at the Becker's 22nd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference features Michael Bottros, Clinical Operations Chief and Medical Director for Pain Services, Department of Anesthesiology, Keck School of Medicine of USC. He shares key trends in non-opioid pain management, the shift toward curative procedures, and how innovation, workforce investment, and care path efficiency are shaping the future of outpatient spine and orthopedic care.

Leadership development is more than titles and advancement—it's a continual process of growth, self-discovery, and adaptation. Part two of our Lifecycle of Leadership series with the Association of Departments of Family Medicine (ADFM) explores how leaders find their voice, navigate common pitfalls like micromanagement and impostor syndrome, and learn to delegate with purpose. Seasoned leaders, Peter Catinella, MD, and Jehni Robinson, MD, FAAFP, discuss the challenges of introverts and extroverts, the importance of mentorship, mastering the language of leadership, and balancing impact with well-being. Our guests offer real-world insights on leading with clarity and intention while embracing progress over perfection.Hosted by Omari A. Hodge, MD, FAAFP and Jay-Sheree Allen Akambase, MDCopyright © Society of Teachers of Family Medicine, 2025Resources:Emerging Leaders FellowshipLeadership through Scholarship FellowshipFamily Medicine Leadership Development OpportunitiesLeadership Opportunities - How to get involved at STFMADFM Leader Development Committee -  Resources from the Leader Development Committee for New & Interim ChairsADFM LEADS FellowshipPeter Catinella, MDDr Catinella has over 30 years of experience in several academic institutions, and currently serves as the as Department Chair at Texas Tech Health Sciences Center El Paso Department of Family Medicine-Transmountain. His prior leadership positions included serving as the Chief Medical Information Officer at the University of Arizona's Health Network and the Clinical Vice Chair in the Department of Family & Community Medicine at the University of Arizona-Tucson, Vice Chair for Clinical Affairs at the Department of Family & Preventive Medicine at the University of Utah and as Director of its Public Health Program, and residency program director at Indiana University. He recently chaired the Leader Development Committee of the Association of Departments of Family Medicine and was a member of its Board of Directors during that tenure.Dr Catinella received his medical degree from the University of Arizona College of Medicine and his Master of Public Health from the University of South Florida. He completed his residency in Family Medicine at Banner Good Samaritan Medical Center in Phoenix, and is certified by the American Board of Family Medicine.Jehni Robinson, MD, FAAFPDr Jehni Robinson is a Professor and Chair of the Department of Family Medicine and Associate Dean for Primary Care at the Keck School of Medicine at the University of Southern California in Los Angeles, CA. She is President of the Association of Departments of Family Medicine (ADFM). Dr Robinson led development of a new Family Medicine residency, graduating its first class in 2024 and co-founded USC Street Medicine Program in 2018, which brings care to unhoused people in Los Angeles. She received the Society of Teachers of Family Medicine (STFM) Advocate Award for this work .  Prior to coming to USC, she served as Chief Medical Officer for The Saban Free Clinic, also known as The Los Angeles Free Clinic, and taught in the Harbor UCLA Transforming Primary Care Faculty Development Fellowship. She received her undergraduate degree from Stanford and her medical degree from Morehouse School of Medicine. She comple

Guest: Jorge Nieva, MD As cancer treatment continues to evolve, at-home subcutaneous immunotherapy is at the forefront of decentralized care and research. Here to share his insights on how this delivery model could impact clinical trials and cancer care is Dr. Jorge Nieva, Associate Professor of Clinical Medicine at the University of Southern California's Keck School of Medicine.

Guest: Jorge Nieva, MD As cancer treatment continues to evolve, at-home subcutaneous immunotherapy is at the forefront of decentralized care and research. Here to share his insights on how this delivery model could impact clinical trials and cancer care is Dr. Jorge Nieva, Associate Professor of Clinical Medicine at the University of Southern California's Keck School of Medicine.

Guest: Jorge Nieva, MD Despite the promising benefits for cancer patients, the at-home administration of subcutaneous immunotherapy poses complex operational and logistical challenges, like cost, payer preferences, and patient safety. Tune in to hear Dr. Jorge Nieva discuss these key factors and considerations impacting the implementation of at-home subcutaneous cancer immunotherapy delivery. Dr. Nieva is an Associate Professor of Clinical Medicine at the University of Southern California's Keck School of Medicine.

Guest: Jorge Nieva, MD As immunotherapy becomes a cornerstone for treating a growing number of solid tumors, reducing the logistical burden of in-office care is essential. Fortunately, the at-home administration of subcutaneous formulations of immunotherapy agents like atezolizumab could help transform the way we care for patients with cancer. Learn more with Dr. Jorge Nieva, Associate Professor of Clinical Medicine at the University of Southern California's Keck School of Medicine.

Guest: Jorge Nieva, MD Despite the promising benefits for cancer patients, the at-home administration of subcutaneous immunotherapy poses complex operational and logistical challenges, like cost, payer preferences, and patient safety. Tune in to hear Dr. Jorge Nieva discuss these key factors and considerations impacting the implementation of at-home subcutaneous cancer immunotherapy delivery. Dr. Nieva is an Associate Professor of Clinical Medicine at the University of Southern California's Keck School of Medicine.

Guest: Jorge Nieva, MD As immunotherapy becomes a cornerstone for treating a growing number of solid tumors, reducing the logistical burden of in-office care is essential. Fortunately, the at-home administration of subcutaneous formulations of immunotherapy agents like atezolizumab could help transform the way we care for patients with cancer. Learn more with Dr. Jorge Nieva, Associate Professor of Clinical Medicine at the University of Southern California's Keck School of Medicine.

Guest: Jorge Nieva, MD Can the immune checkpoint inhibitor atezolizumab be safely administered subcutaneously at home for patients with non-small cell lung cancer (NSCLC)? That's the exact question an ongoing study is seeking to answer, and here to discuss the study's objective, design, and potential implications for home-based subcutaneous cancer therapies is Dr. Jorge Nivea. He's an Associate Professor of Clinical Medicine at the University of Southern California's Keck School of Medicine.

Guest: Jorge Nieva, MD Can the immune checkpoint inhibitor atezolizumab be safely administered subcutaneously at home for patients with non-small cell lung cancer (NSCLC)? That's the exact question an ongoing study is seeking to answer, and here to discuss the study's objective, design, and potential implications for home-based subcutaneous cancer therapies is Dr. Jorge Nivea. He's an Associate Professor of Clinical Medicine at the University of Southern California's Keck School of Medicine.

In this insightful episode of Parallax, Dr Ankur Kalra is joined by Dr Leslie Saxon, a professor of medicine at Keck School of Medicine USC and executive director for the USC Center for Body Computing. Together, they explore the potential network data have in transforming healthcare delivery and patient survival. Beginning with the origin and aim of the USC Center for Body Computing, the episode dives into the benefits of a network of connected implantable devices to engage patients in their own care. Dr Saxon also shares her vision of overseeing "life care” as well as "sick care" by collecting data on the mind and body, providing insights into her work with professional athletes and the military to understand how the body functions as a system. The discussion later turns to the evolution of computing devices and how we are moving past the concept of "wearables" with AI-centric devices designed specifically for continuous health monitoring.

Dean's Chat hosts, Drs. Jeffrey Jensen and Johanna Richey welcome Dr. David Armstrong to the podcast.  This discussion wasn't about the "Diabetic Foot" as much as it was getting to know what makes the world leader in "Diabetic Foot" click.  His background and fascination with technology, intro to podiatry (he considered law) to transforming clinical opportunities at Kern Hospital and UT- San Antonio.   Dr. Armstrong is Distinguished Professor of Surgery and Neurological Surgery with Tenure at the University of Southern California. Dr. Armstrong holds a Master of Science in Tissue Repair and Wound Healing from the University of Wales College of Medicine and a PhD from the University of Manchester College of Medicine, where he was appointed Visiting Professor of Medicine. He is founder and co-Director of the Southwestern Academic Limb Salvage Alliance (SALSA).  Dr. Armstrong has produced more than 720 peer-reviewed research papers in dozens of scholarly medical journals as well as over 120 books or book chapters. He is founding co- Editor of the American Diabetes Association's (ADA) Clinical Care of the Diabetic Foot, now in its fourth edition.  Armstrong is Director of USC's National Science Foundation (NSF) funded Center to Stream Healthcare in Place (C2SHiP) which places him at the nexus of the merger of consumer electronics, wearables, and medical devices in an effort to maximize hospital-free and activity-rich days. Dr. Armstrong was selected as one of the first six International Wound Care Ambassadors and is the recipient of numerous awards and degrees by universities and international medical organizations including the inaugural Georgetown Distinguished Award for Diabetic Limb Salvage. In 2008, he was the 25th and youngest-ever member elected to the Podiatric Medicine Hall of Fame. He was the first surgeon to be appointed University Distinguished Outreach Professor at the University of Arizona. He was also the first podiatric surgeon to be selected as President of Faculty at Keck School of Medicine of USC. Furthermore, he was the first podiatric surgeon to become a member of the Society of Vascular Surgery, and the first US podiatric surgeon named fellow of the Royal College of Surgeons, Glasgow. He is the 2010 and youngest ever recipient of both the ADA's Roger Pecoraro Award and 2023 recipient of the ISDF's Karel Bakker Award, the highest awards given in the field. Dr. Armstrong is past Chair of Scientific Sessions for the ADA's Foot Care Council, and a past member of the National Board of Directors of the American Diabetes Association. He sits on the Infectious Disease Society of America's (IDSA) Diabetic Foot Infection Advisory Committee and is the US appointed delegate to the International Working Group on the Diabetic Foot (IWGDF). Dr. Armstrong is the founder and co-chair of the International Diabetic Foot Conference (DF-Con), the largest annual international symposium on the diabetic foot in the world. He is also the Founding President of the American Limb Preservation Society (ALPS), a medical and surgical society dedicated to building interdisciplinary teams to eliminate preventable amputation in the USA and worldwide. https://limbpreservationsociety.org/ https://bakodx.com/ https://bmef.org/ www.explorepodmed.org https://podiatrist2be.com/  

In 2016, a woman overdosed on meth in a Pasadena hotel room. The man who provided the drugs: Dr. Carmen Puliafito, the dean of USC's Keck School of Medicine. As one reporter at the Los Angeles Times fought to expose the truth, he encountered a power structure that made publishing the story all but impossible.Read Paul's book about this story: https://us.macmillan.com/books/9781250824103/badcity/ For a transcript of this episode: https://bit.ly/campusfiles-transcripts To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

Episode OverviewIn this episode of Spiral Deeper, our host, Gaby Azorsky, speaks with Keely Semler. Together, they dive into her origin story and path to working in the interdisciplinary field of women's reproductive health, judgement in birth, safety, discernment, being a mentor and teacher, her educational course and podcast - Motherlands, and more. Thank you for joining us on this journey of self-discovery and growth! Here is a little more about Keely: Keely's career began with a deep commitment to service, working with a nonprofit that provided medical devices to vulnerable populations in war-torn regions. In her early twenties, Keely traveled to remote parts of Africa and Asia, where she discovered her true calling: to serve and uplift women in their most transformative moments. Driven by this mission, Keely pursued a Master's in Maternal and Child Health from the Keck School of Medicine at the University of Southern California. Upon graduation, she joined a Hospitalist Medical Group, but it was clear her heart lay in direct patient care, where she could make a more personal impact. With this newfound clarity, Keely transitioned to offering her expertise as a Doula and Health Educator, initially providing pro bono support to underserved communities in Los Angeles. Over the years, Keely has supported hundreds of families in both hospital and home settings, always with a focus on holistic, compassionate care. During the pandemic, Keely expanded her knowledge by studying Midwifery Care, which further deepened her understanding of family-centered care. As a student midwife, she reimagined the possibilities of women's health and became devoted to educating and empowering women to honor their bodies, autonomy, and unique paths. Keely's teaching philosophy draws from her background in Public Health, Medical Anthropology, and holistic wellness. This integrated approach allows her to support healthy, informed individuals while also tending to the emotional and energetic dimensions of care. She moves beyond clinical frameworks to explore the deeper ceremony of caregiving and how we show up for one another as a personal, collective, and ecological practice. As her work evolved, Keely offers advance training and mentorship, helping to cultivate the next generation of empowered health educators and professionals.Special OfferCODE - SPIRALOFFLOWERS for 20% off your first month in The Flower Portal!EVENTS - 4/19 Tarot at Noto in Los Angeles, 4/23 Flower Portal Cacao Workshop, 5/30-5/31 The Sacred Pause Retreat in Ojai CaliforniaConnect and Work with GabyInspiring the connection between Heaven and Earth through Reiki, Tarot, Folk herbalism, Clairvoyance, and Meditation. Together, we co-create harmony, clarity, and alignment with your True Essence. I'd love to support you!Visit my website to learn more: gabyazorsky.comFollow me on Instagram: @gaby.azorskyNewsletter: Sign Up HereBook a 1:1 Session: Book HereJoin My Membership, The Flower Portal: Learn MoreWith Spiral DeeperWebsite - Spiral Deeper PodcastInstagram - @spiral.deeperWith Our Guest, Keely SemlerWebsite - https://www.wearemotherlands.com and https://www.keelysemler.comInstagram - @we.are.motherlandsCreditsSpecial thanks to…Music - Connor HayesSpiral Deeper Icon - Kami MarchandCollaborate with UsInterested in advertising or collaborating with Spiral Deeper? Email gabyazorsky@gmail.com for packages and details.Support the ShowPlease rate, review, and subscribe wherever you listen - it means so much. Be sure to tag @spiral.deeper if you share; thank you for your support!

In this episode, we delve into the often-overlooked value of caregiving in a society obsessed with speed and material success. Our guest, Keely Semler, a doula and health educator with a master's in maternal and child health, shares her journey from the nonprofit world to becoming a doula. We discuss the misconceptions about birth, the transformation women experience during pregnancy, and the societal shift away from family values and caregiving. Keely emphasizes the importance of both external resources and internal intuition in navigating the complexities of birth and fertility. Tune in for a profound conversation about the trade-offs women face in modern society and the importance of embracing our innate wisdom.About Keely:Keely's career began with a deep commitment to service, working with a nonprofit that provided medical devices to vulnerable populations in war-torn regions.Driven by this mission, Keely pursued a Master's in Maternal and Child Health from the Keck School of Medicine at the University of Southern California. With this newfound clarity, Keely transitioned to offering her expertise as a Doula and Health Educator, initially providing pro bono support to underserved communities in Los Angeles. Over the years, Keely has supported hundreds of families in both hospital and home settings, always with a focus on holistic, compassionate care. Keely's teaching philosophy draws on her diverse training, including Public Health, Medical Anthropology, and holistic wellness. With this well-rounded approach, she works to foster healthy, informed communities where women are at the center of their care.To connect with Keely:IG: we.are.motherlandsWww.keelysemler.comWww.wearemotherlands.comThe motherlands podcast on Spotify, Apple and Substack.

Geoengineering experiments face an uphill battle, and a way to combat the pregnancy complication hyperemesis gravidarum First up on the podcast, climate engineers face tough conversations with the public when proposing plans to test new technologies. Freelance science journalist Rebekah White joins host Sarah Crespi to discuss the questions people have about these experiments and how researchers can get collaboration and buy-in for testing ideas such as changing the atmosphere to reflect more sunlight or altering the ocean to suck up more carbon dioxide.   Next on the show, hyperemesis gravidarum—severe nausea and vomiting during pregnancy—is common in many pregnant people and can have lasting maternal and infant health effects. This week, Marlena Fejzo wrote about her path from suffering hyperemesis gravidarum to finding linked genes and treatments for this debilitating complication. For her essay, Fejzo was named the first winner of the BioInnovation Institute & Science Translational Medicine Prize for Innovations in Women's Health. Fejzo is a scientist at the Center for Genetic Epidemiology in the department of population and public health sciences at the University of Southern California's Keck School of Medicine.   This week's episode was produced with help from Podigy.   About the Science Podcast   Authors: Sarah Crespi; Rebekah White Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of the Brain & Life Podcast, host Dr. Daniel Correa is joined by comedian and actress Kellye Howard, who shares about her Multiple Sclerosis (MS) diagnosis process and how she manages symptoms in her daily routine. Dr. Correa is then once again joined by Dr. Lilyana Amezcua, a neurologist and MS specialist based out of Los Angeles at USC and the Keck School of Medicine. Dr. Amezcua explains MS and discusses some of the disparities in care amongst different communities.   Additional Resources Expert Insights and Practical Tips for Managing Multiple Sclerosis MS-ing Around with Kellye Howard How Multiple Sclerosis Affects Black People How Exercise Helps Those with Multiple Sclerosis   Other Brain & Life Podcast Episodes Voices from the Multiple Sclerosis Community   We want to hear from you! Have a question or want to hear a topic featured on the Brain & Life Podcast? ·       Record a voicemail at 612-928-6206 ·       Email us at BLpodcast@brainandlife.org   Social Media: Kellye Howard @kellyehoward; Dr. Lilyana Amezcua @keckschoolusc Hosts: Dr. Daniel Correa @neurodrcorrea; Dr. Katy Peters @KatyPetersMDPhD

Geoengineering experiments face an uphill battle, and a way to combat the pregnancy complication hyperemesis gravidarum First up on the podcast, climate engineers face tough conversations with the public when proposing plans to test new technologies. Freelance science journalist Rebekah White joins host Sarah Crespi to discuss the questions people have about these experiments and how researchers can get collaboration and buy-in for testing ideas such as changing the atmosphere to reflect more sunlight or altering the ocean to suck up more carbon dioxide.   Next on the show, hyperemesis gravidarum—severe nausea and vomiting during pregnancy—is common in many pregnant people and can have lasting maternal and infant health effects. This week, Marlena Fejzo wrote about her path from suffering hyperemesis gravidarum to finding linked genes and treatments for this debilitating complication. For her essay, Fejzo was named the first winner of the BioInnovation Institute & Science Translational Medicine Prize for Innovations in Women's Health. Fejzo is a scientist at the Center for Genetic Epidemiology in the department of population and public health sciences at the University of Southern California's Keck School of Medicine.   This week's episode was produced with help from Podigy.   About the Science Podcast   Authors: Sarah Crespi; Rebekah White Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of the St Emlyn's podcast, hosts Iain Beardsell and Liz Crowe welcome Dan Dworkis, an ER doctor from Los Angeles and host of the Emergency Mind podcast. Dan shares his expertise on optimizing team and individual performance in high-stress medical environments. The discussion delves into the concept of excellence beyond merely avoiding negative outcomes, using a rosebush metaphor to illustrate the need for proactive growth. They explore how teams can benchmark and improve performance, the importance of creating a culture of continuous improvement, and strategies to maintain positivity and energy even in challenging conditions. Dan also highlights the Mission Critical Team Institute and its role in supporting teams in life-or-death situations. This episode is essential listening for medical professionals committed to pushing the boundaries of excellence in their practice.   00:00 Introduction and Guest Welcome 01:06 Defining Excellence in Medicine 02:29 Measuring and Achieving Team Performance 06:13 Small Changes for Big Impact 10:03 Maintaining Positivity and Energy 15:30 Mission Critical Team Institute 16:33 Conclusion and Farewell   The Guest - Dan Dworkis Dan Dworkis, MD, PhD, FACEP is the Chief Medical Officer at the Mission Critical Team Institute, the founder of The Emergency Mind Project, a board-certified emergency medicine physician, and an assistant professor at the Keck School of Medicine at USC. His work focuses on the optimal development of mission critical teams in and out of emergency departments. He completed the Harvard Affiliated Emergency Medicine Residency at Massachusetts General Hospital / Brigham Health, and also earned an MD and PhD in molecular medicine from Boston University School of Medicine. Dr. Dworkis is the author of The Emergency Mind:  Wiring Your Brain for Performance Under Pressure.      

In today's episode, supported by Revolution Medicines, we had the pleasure of speaking with Heinz-Josef Lenz, MD, about RAS mutations in pancreatic ductal adenocarcinoma (PDAC). Dr Lenz is a professor of medicine at the Keck School of Medicine of the University of Southern California (USC), as well as the J. Terrence Lanni Chair in Gastrointestinal Cancer Research, co-director of the USC Center for Molecular Pathway and Drug Discovery, and co-director of the USC Norris Center for Cancer Drug Development in Los Angeles. In our exclusive interview, Dr Lenz discussed the prevalence of RAS mutations in PDAC, the importance of biomarker testing, current treatment strategies for patients with RAS-mutant PDAC, and potential future treatment advances for patients with this disease.

Dr. Guy Young, Director of the Hemostasis and Thrombosis Program, Attending Physician in Hematology-Oncology, and Professor of Pediatrics at Keck School of Medicine at the University of Southern California (USC), is currently serving as co-chair of i3 Health's CME/NCPD activity, Practice-Changing Advances in the Management of Hemophilia. With new developments in the field occurring over recent months, Dr. Young sat down with us to share recent updates in the hemophilia treatment and management. Click the links below for the full activity! Online accredited CME/NCPD activity: https://i3health.com/course-information/practice-changing-advances-in-the-management-of-hemophilia Accredited CME/NCPD podcast: https://i3health.com/course-information/practice-changing-advances-in-the-management-of-hemophilia-podcast

Send us a text In this episode of Causes or Cures, Dr. Eeks sits down with Dr. Sherlock Li to explore his recent research on the impact of forever chemicals (PFAS) on sleep, a pressing public health concern given the strong links between poor sleep and a range of health issues. Dr. Li begins by providing an overview of what forever chemicals are and how they persist in the environment and human body. He then delves into the methodology of his latest study, detailing the observed effects of PFAS on sleep patterns and the emerging theories behind these disruptions. The conversation also touches on the broader public health implications of PFAS exposure and Dr. Li's cautionary note that the replacement chemicals being introduced may not offer any improvements for our well-being. Dr. Sherlock Li, PhD, is a postdoctoral researcher in the Department of Population and Public Health Sciences at the Keck School of Medicine. You can contact Dr. Eeks at bloomingwellness.com.Follow Eeks on Instagram here.Or Facebook here.Or X.On Youtube.Or TikTok.SUBSCRIBE to her monthly newsletter here.Support the show

Dr. John Martin is a virologist and medical researcher who has greatly contributed to the study of viral infections and their role in chronic diseases. He is the medical director of the Institute for Progressive Medicine at the non-profit charity MI Hope that supports those with mental illness. During his tenure at the National Institute of Allergy and Infectious Diseases (NIAID) Dr. Martin significantly increased our understanding of viruses such as HIV, hepatitis, and herpesviruses. He later worked as Chief of the FDA's Virus Oncology Laboratory evaluating vaccine safety, especially vaccine contamination with adventitious agents, which led to his interest in stealth-adapted viruses -- viruses that are not recognized by our immune system. This research led to his theory that such stealth pathogens, such as simian cytomegalovirus contamination in the polio vaccines, could contribute to a wide range of chronic illnesses including neuropsychiatric disorders such as autism and chronic fatigue. Following his work in government health agencies, John was a professor of pathology at the Keck School of Medicine at the University of Southern California. His current research is focused on Kinetic Energy Limiting Electrostatic Attraction or KELEA, which can aid immune function, suppress stealth viruses, enhance water for crops and for purifying ecological environments. He holds an MD and a separate PhD from the University of Sydney and University of Melbourne respectively.   

Patrick Crispen, Director of Educational Technology at Keck School of Medicine of USC and frequent contributor on The Steve and Johnnie Show, joins Lisa Dent for an update from the ground in Los Angeles. Patrick and his family are among thousands of other residents who have been forced to evacuate their homes as winds reaching […]

Today we are bringing you insights from 3 separate interviews with experts about the treatment, management, and burdens of idiopathic pulmonary fibrosis (IPF). In this podcast, you'll hear insight from the following individuals: Toby Maher, MD, PhD, professor of clinical medicine, Keck School of Medicine, USC; Martin Kolb, MD, PhD, professor of medicine, McMaster University; and Steven Nathan, MD, FCCP, medical director of the Advanced Lung Disease Program and Lung Transplant Program, Inova Fairfax Hospital, and professor of medicine, University of Virginia. These experts discuss what IPF is, how it impacts patients' quality of life, barriers to care, and treatments in the pipeline.

As we get closer to 2025, Johnnie Putman and Steve King return with another show to prep you for the holiday! It’s a shorter show, but a great show nonetheless! We catch up with Patrick Crispen, Director of Educational Technology at Keck School of Medicine of USC on the latest tech news and phone problems. […]

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: A push to change the defined stages of T1D, InsuJet is approved in Canada, new study linked T2D and dementia, new drug looked at to prevent hypoglycemia, big honors for a T1D author and more! Our interview with Clare Edge here.  Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Edgepark Medical Supplies Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens  Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:     Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX   The understanding of type 1 has changed a lot in the last 10-15 years, specifically with the definition of stages of the disease. Now some researchers suggest the current 2015 model is ready for another update. University of Florida Health diabetes researchers and collaborators last week issued a call to action in The Lancet Diabetes & Endocrinology, urging the development of a more precise method of calculating type 1 diabetes risk. Under the current staging system, this is Stage 1 of the disease, when a patient does not yet have elevated blood sugar but has two or more of these autoantibodies in the blood. Stage 2 is diagnosed when blood sugar begins to rise, indicating a dysfunctional pancreas in a patient who does not yet have clinical type 1 diabetes. That comes in Stage 3 with high blood sugar and, eventually, the classic symptoms of the disease, including frequent urination, weight loss and fatigue. Jacobsen, however, said the staging system requires more precision. This is especially important as the current staging model determines if a patient is eligible to receive a drug therapy called teplizumab, the only Food and Drug Administration-approved medication that can delay the onset of type 1 diabetes by an average of two years. The staging system, however, does not include a patient's age and these researchers say additional markers that would be important to consider include a greater array of abnormal metabolic measures beyond blood sugar and the presence of more autoantibodies.   https://www.gainesville.com/story/news/healthcare/2024/12/04/uf-health-scientists-propose-update-to-type-1-diabetes-staging-system/76734459007/ XX A product called InsuJet gets approval in Canada. Made by NuGen Medical Devices, InsuJet™ is a needle-free injection system. It's already approved for sale in 42 countries – not yet the US. Their website says InsuJet's jet-injected fluid penetrates the skin through a small orifice of a special nozzle, creating a thin, high pressure stream. This way, insulin doesn't remain around the place of injection, like it does with a needle. Instead, with InsuJet, the insulin is deposited into the subcutaneous tissue where it's easily absorbed and acts faster– saving you money, time, and discomfort.   https://finance.yahoo.com/news/nugen-announces-canada-wide-launch-221500674.html XX Individuals diagnosed with type 2 diabetes before the age of 50 may be at a higher risk of developing dementia later in life. A study led by researchers at NYU Rory Meyers College of Nursing, says the risk is notably greater among adults with obesity. Type 2 diabetes is a known risk factor for dementia. Although the underlying mechanisms are not fully understood, scientists think that some of the hallmarks of diabetes—such as high blood sugar, insulin resistance, and inflammation—may encourage the development of dementia in the brain.     The researchers note that this greater understanding of the connection between diabetes onset, obesity, and dementia may help inform targeted interventions to prevent dementia. https://scitechdaily.com/diagnosed-young-with-diabetes-your-dementia-risk-may-be-higher/ XX Embecta is out of the insulin patch pump business – just months after getting the ok from the FDA. Embecta received FDA clearance for its insulin patch pump in September. The device is indicated for people with Type 1 or Type 2 diabetes and includes a 300-unit insulin reservoir to support people with higher daily insulin needs. However, the version Embecta received clearance for was an open-loop patch pump, where users manually control insulin delivery, while the firm's goal was to develop a closed-loop version, which automatically delivers insulin when needed. The CEO also expects competition in closed-loop devices for people with Type 2 diabetes to intensify, with Insulet receiving FDA clearance for its Omnipod 5 patch pump for Type 2 diabetes in August. https://www.medtechdive.com/news/embecta-discontinue-patch-pump/734059/ XX Sanofi invests in a company developing a new drug to prevent hypoglycemia. We reported on Zucara Therapeutics back in 2022 and they've been moving ahead with ZT-01. ZT-01 is a medication being developed to help prevent dangerous low blood sugar (hypoglycemia) by fixing how the body normally fights it. In people without diabetes, a hormone called glucagon is released to raise blood sugar when it gets too low. But in people with insulin-dependent diabetes, like type 1 diabetes or some forms of type 2 diabetes, this process doesn't work well because another hormone, somatostatin (SST), blocks glucagon from being released. ZT-01 works by blocking the effects of somatostatin, allowing the body to release more glucagon when it's needed. This could help people with diabetes avoid severe low blood sugar episodes.   https://www.prnewswire.com/news-releases/zucara-therapeutics-announces-strategic-investment-from-sanofi-as-part-of-us20-million-series-b-financing-302301820.html XX Omnipod 5 is now compatible with the FreeStyle Libre 2 plus. The company says the recent development “ makes Omnipod 5 the most connected tubeless AID system in the U.S.” It's already compatible with Dexcom's G6 and G7 CGMs. https://www.businesswire.com/news/home/20241120268759/en/Insulet-Announces-Omnipod%C2%AE-5-System-is-Now-Compatible-with-Abbott%E2%80%99s-FreeStyle-Libre-2-Plus-Sensor-in-the-U.S. XX A new study involving 11 clinical centers across the United States aims to uncover how type 1 diabetes (T1D) impacts brain health and cognitive function in children. Led by the Keck School of Medicine of the University of Southern California, this is a five-year study to explore critical questions about how environmental, lifestyle, social and clinical factors affect brain development during childhood — a period crucial for cognitive growth. https://www.managedhealthcareexecutive.com/view/new-study-to-explore-impact-of-type-1-diabetes-on-children-s-brain-development XX Dexcom looking to partner with smart ring company Oura. Originally launched to track sleep patterns, the latest Oura technology collects more than 20 biometrics ranging from heart rate and activity metrics to sleep and body temperature monitoring. The companies say the new partnership is intended to provide users with seamless integration between the two ecosystems so shared users can track their glucose levels and understand the impact of behaviors and biology on their metabolic health. https://www.forbes.com/sites/saibala/2024/11/29/smart-ring-maker-oura-hits-5-billion-in-valuation--strikes-major-partnership-with-dexcom/ XX   WEDNESDAY, Dec. 4, 2024 (HealthDay News) -- Taking even high doses of supplementary vitamin D won't lower an older person's odds for type 2 diabetes, new research confirms. They published their findings Dec. 2 in the journal Diabetologia. The new research followed on data from other studies that had suggested that people with especially low levels of vitamin D might face a higher risk for diabetes. That was true for people who were already prediabetic, especially. To find out, researchers led by Jirki Vyrtanen, from the University of Eastern Finland, randomly assigned nearly 2,300 people aged 60 or older to receive either placebo pills or 40 or 80 micrograms of vitamin D3 supplements per day, for five years.  At the end of the five years, "105 participants developed type 2 diabetes: 38 in the placebo group, 31 in the group receiving 40 micrograms of vitamin D3 per day, and 36 in the group receiving 80 micrograms of vitamin D3 per day," according to a university news release. In other words, there were no significant differences in the rate at which people developed type 2 diabetes, regardless of how much supplemental vitamin D they took. Vytanen's team also saw no benefit from high-dose supplements on a person's blood sugar or insulin levels, or measures of overweight/obesity. The bottom line, according to the researchers: For any healthy, non-prediabetic person with healthy vitamin D levels, upping intake of the vitamin won't alter your odds for diabetes or its common risk factors. https://www.usnews.com/news/health-news/articles/2024-12-04/high-dose-vitamin-d-supplements-wont-prevent-diabetes-in-healthy-seniors XX Big congrats to author Clare Edge – recent guest on the podcast. Her book, Accidental Demons is featured on People Magazine's top ten book gift suggestions for this year! Whether you're looking for books about winter and the holidays, a primer on some of this year's buzziest musicians and characters or that "one more chapter" kind of bedtime favorite, there's sure to be a book out there to suit their taste. Bernadette Crowley, also known as Ber, comes from a long line of witches. When Ber is diagnosed with diabetes, however, she learns that every time she tests her blood sugar, demons accidentally slip into the human dimension — and it's up to Ber and her sister, Maeve, to stop them. This fantastical book is a great escape for young readers over holiday break. Buy Now Top ten books https://people.com/kids-gift-book-suggestions-wicked-taylor-swift-books-8752097

TopMedTalk at The American Society of Anesthesiologists (ASA)'s annual general meeting; Anesthesiology 2024. We're bringing you a series of podcasts from the conference. Make sure you check our podcast feed and are subscribed to TopMedTalk, as we are currently releasing episodes more often than usual to accommodate high demand. This piece provides much needed focus on the topic of pediatrics and hemodynamics. Is it true to say that children are completely different to adults? What information do we need and what should the considerations around this topic really be? Presented by Desiree Chappell and Mike Grocott with their guests Dwight Bailey, Chief, Division of Pediatric Critical Care Medicine at Atrium Health, Levine Children's Hospital and Jonathan Tan, Vice Chair of Analytics and Clinical Effectiveness, Department of Anesthesiology Critical Care Medicine, Assistant Professor of Clinical Anesthesiology and Spatial Sciences, Children's Hospital Los Angeles, Keck School of Medicine of the University of Southern California, Spatial Sciences Institute of the University of Southern California

In this episode, hosts Dr. Kevin Chu and Dr. Justin Dubin engage in a timely discussion about the evolving landscape of male birth control options. With limited access to abortion services in many states, the need for men to take responsibility in family planning has never been more crucial. The hosts welcome Dr. Brian Nguyen, a leading expert in complex family planning and associate professor at the Keck School of Medicine at USC. Dr. Nguyen shares valuable insights into the promising developments in male contraceptives currently in clinical trials, emphasizing the importance of providing men with effective, temporary options. While the hosts advocate for vasectomies as a permanent solution for those who no longer wish to have children, they recognize that not everyone is ready for that step. They discuss the potential of various innovative methods, including the role of testosterone as a male contraceptive, and clarify common misconceptions about male fertility while on testosterone therapy. Learn more about the significance of expanding contraceptive options for men and how this can positively impact family planning. Tune in now on Spotify, Apple Podcasts, Amazon, and YouTube! #podcast #menshealth #fertility #contraceptive #reproductivehealth #healthcare #optimalwellness #men #wellness

In this episode of AI @ HLTH on The Beat, Sandy Vance speaks with Dr. Benjamin Nguyen from Transcarent about the innovative Wayfinding platform, which integrates AI to enhance healthcare navigation for employees. They discuss the challenges of healthcare engagement, the importance of personalized experiences, and the role of AI and LLMs in transforming healthcare delivery. Dr. Nguyen emphasizes the need for privacy and security in healthcare AI solutions and shares insights on the future of AI in the industry.In this Episode they discuss:Employees deserve benefits that empower them with guidance.Transcarent aims to simplify healthcare navigation.Wayfinding connects various healthcare solutions in one platform.Healthcare complexity leads to disengagement among employees.AI can provide personalized healthcare experiences.LLMs enhance engagement by tailoring responses to individuals.Privacy and security are paramount in healthcare AI.Transcarent does not train LLMs on customer data.The future of healthcare will see more subtle AI integration.Investing in innovative solutions is key for employers.A little about Dr. Benjamin Nguyen: Dr. Benjamin (Ben) Nguyen, M.D. is a healthcare and AI product leader. At Transcarent, Dr. Nguyen currently leads the Transcarent AI team which is tasked with expanding Transcarent's suite of AI products while maintaining the highest standards for patient safety. Throughout his career, Dr. Nguyen has led multiple teams building AI products ranging from hospital AI deployment platforms, radiology AI safety applications, chatbots for patients, and AI tools for clinicians. Dr. Nguyen is known as an expert on AI in healthcare, and was recently called to testify before Congress on the subject, educating lawmakers and the public about the potential and safety risks of AI. He is also a guest lecturer at the University of Southern California, where he teaches about AI fundamentals and safety in healthcare. Dr. Nguyen received his Doctor of Medicine degree at the Keck School of Medicine of USC, as well as graduate specialization certificates from the Marshall School of Business and the Viterbi School of Engineering. He is a Bay Area native and lives in San Francisco, California.

Send us a text In this episode of Causes or Cures, Dr. Eeks sits down with Dr. Hooman Allayee and James Hilser to explore their new research on the lasting impact of COVID-19 on heart health. They reveal surprising findings about how COVID—especially in those who were hospitalized—elevates the risk of severe heart issues long after recovery, even years down the road. The conversation dives into the connection between blood type and post-COVID heart risk, and the researchers share their theories on why blood type matters. Plus, they discuss the implications of these findings for public health and clinical practice, offering important recommendations for how the public health and medical community should respond. Dr. Allayee is a professor of populations and public health sciences and biochemistry and molecular medicine at the Keck School of Medicine of USC. His research focuses on utilizing genetics and genomics to better understand complex cardiovascular, metabolic, and inflammatory diseases. James Hilser holds a masters of public health, is a bioinformatics specialist and a PhD candidate in molecular medicine in the Department of Population and Public Health Sciences at Keck School of Medicine. *New* SUBSCRIBE for Causes or Cures+ Bonus Episodes!You can contact Dr. Eeks at bloomingwellness.com.Follow Eeks on Instagram here.Or Facebook here.Or X.On Youtube.Or TikTok.SUBSCRIBE to her monthly newsletter here.Support the show

Welcome to This Week in Pharmacy where we touch base on Pharmacy Times Reports on "Community Pharmacy's Existential Question: Should you Chase Product Revenues or Service Margins by Troy Trygstag PharmD. We talk about the Ohio Capital article on PBMs skimming millions of dollars from tax-payers, and Forbes reports on Mark Cuban Cost Plus Drugs is disrupting the PBM contracts and their work with Blue Shield of California. Big time news!!  Let's talk about Wound Care on This Week in Pharmacy: William Padula, PhD from the Alfred E. Mann School of Pharmacy & Pharmaceutical Sciences and-or David G. Armstrong MD from the Keck School of Medicine of USC, are talking with Todd Eury on TWIRx about a recent proposal from Medicare is calling to  eliminate coverage of some of skin substitute therapies, and the potential serious health risks that many Americans will face by limiting them. Skin substitutes, made from donated amniotic tissue, greatly improve wound care outcomes and help patients avoid limb amputations—a procedure that can double the risk of death for diabetic patients. This Medicare proposal under consideration will deny coverage of over 200 skin substitutes and limit how doctors can properly treat patients will leave tens of thousands of Medicare beneficiaries without treatment.

Sarah Hill, professor of social psychology at Texas Christian University and author of This is your brain on birth control: The surprising science of sex, women, hormones and the law of unintended consequences, shares her journey into exploring the effects of oral contraception on mental health.  “I actually spent my early career studying the way our sex hormones can affect psychological states and motivation…and the desire to attract romantic partners.” It wasn’t until Hill went off oral contraception herself that she began to connect the dots. “I started to feel so differently, that I started to really wonder what we did not know and about the way the pill affects the brain and the way that women experience the world.” Hill recounts  her personal experience and the research she conducted on the Pill’s effects, highlighting a range of impact on physical and mental wellbeing. Everything from “having less energy” to “being at a greater risk for depression and anxiety,” and how “it can reduce sexual desire and sexual functioning.” Emily Dossett, a clinical associate professor of Psychiatry & the Behavioral Sciences at USC’s  Keck School of Medicine, addresses another often-overlooked aspect of  women’s health: the prevalence of mental health disorders before, during, and after pregnancy. Dossett underscores  that “pregnancy is a time of tremendous and rapid physiological change,” and that “if a woman is susceptible, really to anything; diabetes, hypertension, cardiac disorders,” that pregnancies with those disorders “are more likely to come to the forefront or even emerge for the first time. The same is true for mental illness.” Dossetts points out  that society tends to attach  immense  joy to pregnancy and the celebration of pregnancy that women feel ashamed, even stigmatized, if they mention or complain about how they feel. “We're just realizing how common some of these challenges are in terms of mental health because we're just now at a point where we're allowing women to actually speak up about it.” Roughly “one out of every four to five women” suffer from some kind of mental disorder, Dossett says, with depression and  anxiety being most common.    Because there has been little research on women’s mental health and pregnancy, Dossestt explains that there’s a general “lack of understanding and comprehension and naming of these disorders in the mental health world.” And when it comes to medication; “ the FDA, which approves all drugs, does not permit pregnant or lactating people to be included in drug trials.” So, what options are available for  women who require medication and aspire to conceive? “The question is not really whether or not these medications are safe but it's more of a risk, risk analysis for each individual person,” Dossett says.   “I firmly believe everyone has the right to have a child. Everyone has the right to not have a child and everyone has the right to raise a child in a safe and healthy environment. Those are the tenets of what we call reproductive justice. And I believe they apply to people with mental illness just like anyone else.”  Delve deeper into life, philosophy, and what makes us human by joining the Life Examined discussion group on Facebook.